Page 20 - PowerPoint Presentation

Scalable Business Model

$1-5MM $3-15MM $5-25MM $15-40MM $20-50MM
1-10 years 1-2 years 1-3 years 1-3 years 0.5-2 years

+$1B; 246%
87%
PoS= 87% Revenue
+$527M; 358% Value= $1.8B $2B over 10 years
42%
PoS= 36.5%
+$167M; 554% Value= $731M $44-135MM
28% Regulatory 5-20 years
+$35M; 2044% PoS= 10.2% Approvals
Value= $204M Pivotal Trial(s) Commercial
PoS= 1.8% 18% GMP Validation Launch 13%
Value= $36.8M
PoS= 0.09% 5% GMP Mfg / 58%
Value= $1.8M Ph I / Ph II Trials
Preclinical / 72%
Mfg scale-up Focused on the largest value creation
R&D 82% & least capital-intensive segment

• Not on drug molecule research
95%
• Not on clinical trials